Addex Therapeutics Ltd header image

Addex Therapeutics Ltd

ADXN

Equity

ISIN CH0029850754 / Valor 2985075

SIX Swiss Exchange (2026-08-06)
CHF 0.039-3.96%

Addex Therapeutics Ltd
UMushroom community rating:

star star star star star
4.00 1 votes No rating yet
NegativeNeutralPositive

About company

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company based in Geneva that develops small‑molecule allosteric modulators, primarily targeting G protein‑coupled receptors and other central nervous system targets, with the aim of producing more selective therapies for neurological and neuropsychiatric disorders. Its pipeline has emphasized mGlu5 negative allosteric modulation for levodopa‑induced dyskinesia in Parkinson’s disease and related CNS indications, and the company combines proprietary discovery capabilities with external collaborations to advance candidates through preclinical and clinical development.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-28.1%1Y
-60.3%3Y
-97.6%5Y

Performance

74.4%1Y
96.2%3Y
97.7%5Y

Volatility

Market cap

6 M

Market cap (USD)

Daily traded volume (Shares)

150,724

Daily traded volume (Shares)

1 day high/low

0.058 / 0.0528

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

1 votes
Performance:
starstarstarstarstar
2.00
Innovation:
starstarstarstarstar
5.00
Society:
starstarstarstarstar
5.00
Nature:
starstarstarstarstar
3.00
Daniela Gie
Germany, 19 Jun 2024
star star star star star
Hedge found is betting on that stock. (Steven Boyd's Armistice Capital ).

EQUITIES OF THE SAME SECTOR

BridgeBio Pharma Inc
BridgeBio Pharma Inc BridgeBio Pharma Inc Valor: 48204826
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.99%USD 82.80
Alkem Laboratories Ltd.
Alkem Laboratories Ltd. Alkem Laboratories Ltd. Valor: 30689895
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.96%INR 5,608.45
Insmed Inc
Insmed Inc Insmed Inc Valor: 12614415
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
33.86%USD 132.55
Laurus Labs Ltd.
Laurus Labs Ltd. Laurus Labs Ltd. Valor: 56464789
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.36%INR 1,836.00
Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited Alembic Pharmaceuticals Limited Valor: 11500585
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.27%INR 834.60
Narayana Hrudayalaya Ltd.
Narayana Hrudayalaya Ltd. Narayana Hrudayalaya Ltd. Valor: 30795490
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.98%INR 1,883.80
Metropolis Healthcare Ltd.
Metropolis Healthcare Ltd. Metropolis Healthcare Ltd. Valor: 11536062
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.76%INR 562.55
Cohance Lifesciences Ltd
Cohance Lifesciences Ltd Cohance Lifesciences Ltd Valor: 46346459
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.54%INR 439.85
Gland Pharma Ltd.
Gland Pharma Ltd. Gland Pharma Ltd. Valor: 56038514
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.82%INR 2,617.50
MEDICLIN AG
MEDICLIN AG MEDICLIN AG Valor: 1158721
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.31%EUR 4.22